MedPath

Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg

Phase 3
Completed
Conditions
Chronic Heart Failure
Registration Number
NCT00272805
Lead Sponsor
Cardiovascular Clinical Studies
Brief Summary

The purpose of this study is to compare dosing compliance between study patients taking controlled release carvedilol once a day, and study patients taking immediate release carvedilol (Coreg) twice a day.

Detailed Description

Study Further Study Details:

Primary outcome: pill-taking compliance (total doses taken versus total doses prescribed)

Expected Total Enrollment: 400 subjects at 56 study sites in the U.S.

Study Start: October 2005

This is a 5-month double-blind treatment study of male and female subjects with stable mild-to-severe chronic heart failure and with left ventricular dysfunction with symptoms of heart failure.

Eligibility:

Must be stable on treatment with Coreg IR at a standard dose: 6.25, 12.5, 25 mg twice a day.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Ability to read English
  • Stable symptoms of mild to severe heart failure
  • Stable medical regimen for heart failure
  • On a stable dose of Coreg for at least 2 months
  • LVEF ≤40% within the previous 24 months
Exclusion Criteria
  • Uncorrected obstructive or regurgitant valve disease
  • Complex congenital heart disease
  • Recent ICD or pacemaker placement
  • Recent coronary artery bypass surgery or stroke
  • Candidate for heart transplanct within 5 months of study start
  • Present or planned use of MAO inhibitors, alfpha-blockers, combined alpha-beta blockers, any Class I/II anti-arrythmnic agents, (amiodarone may be used if ≤ 200mg/day). Use of intravenous vasodilator/inotropic agents.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Dosing compliance: pill taking total taken vs number prescribed
Secondary Outcome Measures
NameTimeMethod
quality of life

Trial Locations

Locations (51)

Idaho Cardiology Associates

🇺🇸

Boise, Idaho, United States

St. Francis Hospital and Medical Center

🇺🇸

Hartford, Connecticut, United States

Charlotte Heart Group Research Center

🇺🇸

Port Charlotte, Florida, United States

CVMS Research Institute of Augusta

🇺🇸

Augusta, Georgia, United States

Cardiovascular Consultants of Maine

🇺🇸

Scarborough, Maine, United States

The Heart and Vascular Institute of Florida

🇺🇸

St. Petersburg, Florida, United States

Cardiac Disease Specialists

🇺🇸

Atlanta, Georgia, United States

Pentucket Medical Associates

🇺🇸

Haverhill, Massachusetts, United States

Associated Cardiovascular Consultants

🇺🇸

Cherry Hill, New Jersey, United States

South Bay Cardiovascular Associates

🇺🇸

West Islip, New York, United States

New York University Medical School

🇺🇸

New York, New York, United States

Lahey Clinic Cardiology

🇺🇸

Burlington, Massachusetts, United States

Bryan LGH Heart Institute

🇺🇸

Lincoln, Nebraska, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Albany Associates in Cardiology

🇺🇸

Albany, New York, United States

Akron General Medical Center

🇺🇸

Akron, Ohio, United States

The Care Group

🇺🇸

Indianapolis, Indiana, United States

NextPhase Clinical Trials

🇺🇸

Miami, Florida, United States

San Diego Cardiac Center

🇺🇸

San Diego, California, United States

Lovelace Scientific Resources

🇺🇸

Las Vegas, Nevada, United States

The Lindner Clinical Trial Center

🇺🇸

Cincinnati, Ohio, United States

New Horizons Clinical Research

🇺🇸

Cincinnati, Ohio, United States

Cardiovascular Consultants of Oregon

🇺🇸

Corvallis, Oregon, United States

The Heart Group

🇺🇸

Mobile, Alabama, United States

Cardiology Consultants of Orange County

🇺🇸

Anaheim, California, United States

Cardiovascular Consultants Medical Group

🇺🇸

Walnut Creek, California, United States

Access Clinical Trials

🇺🇸

Beverly Hills, California, United States

Northern California Medical Associates

🇺🇸

Santa Rosa, California, United States

Heart Center of the Rockies

🇺🇸

Fort Collins, Colorado, United States

Georgia Heart Specialists

🇺🇸

Covington, Georgia, United States

Androscoggin Cardiology Associates-Research

🇺🇸

Auburn, Maine, United States

Illinois Heart and Lung Research Center

🇺🇸

Normal, Illinois, United States

North Shore Cardiologists

🇺🇸

Bannockburn, Illinois, United States

Maine Cardiology Associates

🇺🇸

S.Portland, Maine, United States

Midwest Heart Foundation

🇺🇸

Lombard, Illinois, United States

Clinical Trials Management

🇺🇸

Metairie, Louisiana, United States

Primary Care Cardiology Research

🇺🇸

Ayer, Massachusetts, United States

MidValley Cardiology

🇺🇸

Kingston, New York, United States

University of New Mexico Health Science Center

🇺🇸

Albuquerque, New Mexico, United States

Cardiovascular Medical Associates

🇺🇸

Garden City, New York, United States

Alamance Regional Medical Center

🇺🇸

Burlington, North Carolina, United States

North Ohio Research Ltd.

🇺🇸

Sandusky, Ohio, United States

The Dayton Heart Center

🇺🇸

Dayton, Ohio, United States

Blue Stem Cardiology

🇺🇸

Bartlesville, Oklahoma, United States

Oregon Medical Group Clinical Research

🇺🇸

Eugene, Oregon, United States

Guthrie Clinic Ltd.

🇺🇸

Sayre, Pennsylvania, United States

Rhode Island Heart Failure Center

🇺🇸

Providence, Rhode Island, United States

Arrythmia Center for Southern Wisconsin

🇺🇸

Elkhorn, Wisconsin, United States

LDS Hospital Cardiovascular Research

🇺🇸

Salt Lake City, Utah, United States

DCOL Center for Clinical Research

🇺🇸

Longview, Texas, United States

Radiant Research

🇺🇸

Santa Rosa, California, United States

© Copyright 2025. All Rights Reserved by MedPath